Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed
The construction of PD-L1 risk model was of great significance for the treatment of lung adenocarcinoma.
Authors
- Wentao Hu (ORCID: https://orcid.org/0000-0001-8495-4175)
- Cheng Wang (ORCID: https://orcid.org/0000-0002-1834-2119)
- Jian Chen (ORCID: https://orcid.org/0000-0002-1694-7763)
- Weijun Zhao
- Simeng Ren
- Meng Li-Fei
Institutions
- Ningbo University (CN)
- Wenzhou-Kean University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fimmu.2025.1601982
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14